The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp decreased its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 4.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,242,754 shares of the medical device company's stock after selling 60,082 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.62% of Cooper Companies worth $104,826,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. T. Rowe Price Investment Management Inc. boosted its position in shares of Cooper Companies by 2.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company's stock worth $705,928,000 after acquiring an additional 155,233 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Cooper Companies by 1.5% during the 4th quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company's stock worth $460,066,000 after acquiring an additional 74,501 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Cooper Companies by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company's stock worth $449,907,000 after acquiring an additional 109,907 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Cooper Companies by 517.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock worth $324,466,000 after acquiring an additional 2,957,421 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Cooper Companies in the 4th quarter valued at about $217,906,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

Cooper Companies Trading Down 2.5%

Shares of COO stock traded down $1.93 during mid-day trading on Friday, hitting $74.77. 2,517,933 shares of the company's stock were exchanged, compared to its average volume of 1,741,694. The Cooper Companies, Inc. has a fifty-two week low of $65.00 and a fifty-two week high of $112.38. The stock has a market cap of $14.95 billion, a price-to-earnings ratio of 36.30, a PEG ratio of 1.87 and a beta of 0.99. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The stock has a 50-day simple moving average of $74.92 and a two-hundred day simple moving average of $82.71.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The firm had revenue of $1 billion for the quarter, compared to analysts' expectations of $995.12 million. During the same quarter last year, the firm earned $0.85 earnings per share. The firm's revenue for the quarter was up 6.3% compared to the same quarter last year. Equities analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Needham & Company LLC raised Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 target price for the company in a research report on Tuesday, June 17th. Robert W. Baird cut their target price on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research note on Friday, May 30th. Loop Capital set a $100.00 price objective on Cooper Companies in a research note on Tuesday, June 17th. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $76.00 target price (down previously from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Finally, Wall Street Zen cut Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, Cooper Companies currently has a consensus rating of "Moderate Buy" and a consensus target price of $99.70.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.